Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:2786-2792
Published online before print November 26, 2007, doi: 10.1161/CIRCULATIONAHA.107.711622
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Circulation: December 11, 2007, Volume 116, Number 24
Right arrow All Versions of this Article:
116/24/2786    most recent
CIRCULATIONAHA.107.711622v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moreira, W.
Right arrow Articles by Rodriguez, L.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moreira, W.
Right arrow Articles by Rodriguez, L.-M.
Related Collections
Right arrow Electrophysiology
Right arrow Ablation/ICD/surgery
Right arrow Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2007;116:2786-2792.)
© 2007 American Heart Association, Inc.


Arrhythmia/Electrophysiology

Can Common-Type Atrial Flutter Be a Sign of an Arrhythmogenic Substrate in Paroxysmal Atrial Fibrillation?

Clinical and Ablative Consequences in Patients With Coexistent Paroxysmal Atrial Fibrillation/Atrial Flutter

Wendel Moreira, MD; Carl Timmermans, MD, PhD; Hein J.J. Wellens, MD, PhD; Yuka Mizusawa, MD; Suzanne Philippens, RN; David Perez, MD; Luz-Maria Rodriguez, MD, PhD

From the Department of Cardiology, Academic Hospital Maastricht (W.M., C.T., Y.M., S.P., D.P., L.-M.R.) and Cardiovascular Research Institute Maastricht (H.J.J.W.), Maastricht, the Netherlands.

Correspondence to Luz-Maria Rodriguez, MD, PhD, Department of Cardiology, Academic Hospital Maastricht, P. Debyelaan 25, PO Box 5800, Maastricht, the Netherlands. E-mail lm.rodriguez{at}cardio.unimaas.nl

Received April 26, 2007; accepted September 28, 2007.

Background— The coexistence of atrial fibrillation (AF) and atrial flutter (AFL) is well recognized. AF precedes the onset of AFL in almost all instances. We evaluated the effect of 2 ablation strategies in patients with paroxysmal AF (PAF) and AFL.

Methods and Results— Ninety-eight patients with PAF/AFL were prospectively recruited to undergo pulmonary vein cryoisolation (PVI). Those with at least 1 episode of sustained common-type AFL were assigned to cavotricuspid isthmus cryoablation followed by a 6-week monitoring period and a subsequent PVI (n=36; group I). Patients with PAF only underwent PVI (n=62; group II). The study included 76 men with a mean age of 50±10 years. Most patients (76 [78%]) had no structural heart disease. When the 2 groups were compared, residual AF after a blanking period of 3 months after PVI occurred in 24 patients (67%) in group I versus 7 (11%) in group II (P<0.05).

Conclusions— In patients with PAF and no documented common-type AFL, PVI alone prevented the occurrence of AF in 82%, whereas in patients with AFL/PAF, cavotricuspid isthmus cryoablation and PVI were used successfully to treat sustained common-type AFL but appeared to be insufficient to prevent recurrences of AF. In this population, AFL can be a sign that non–pulmonary vein triggers are the culprit behind AF or that sufficient electrical remodeling has already occurred in both atria, and thus a strategy that includes substrate modification may be required.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Circ Arrhythm ElectrophysiolHome page
F. J. Perez, C. M. Schubert, B. Parvez, V. Pathak, K. A. Ellenbogen, and M. A. Wood
Long-Term Outcomes After Catheter Ablation of Cavo-Tricuspid Isthmus Dependent Atrial Flutter: A Meta-Analysis
Circ Arrhythm Electrophysiol, August 1, 2009; 2(4): 393 - 401.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J Pontoppidan, J C Nielsen, S H Poulsen, H K Jensen, H Walfridsson, A K Pedersen, and P S Hansen
Prophylactic cavotricuspid isthmus block during atrial fibrillation ablation in patients without atrial flutter: a randomised controlled trial
Heart, June 15, 2009; 95(12): 994 - 999.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. L. Waldo
Atrial Fibrillation Atrial Flutter Interactions: Clinical Implications for Ablation
Circulation, December 11, 2007; 116(24): 2774 - 2775.
[Full Text] [PDF]